113 related articles for article (PubMed ID: 3825912)
1. Pharmacodynamics of 3-hydroxyquinidine alone and in combination with quinidine in healthy persons.
Vozeh S; Bindschedler M; Ha HR; Kaufmann G; Guentert TW; Follath F
Am J Cardiol; 1987 Mar; 59(6):681-4. PubMed ID: 3825912
[TBL] [Abstract][Full Text] [Related]
2. Greater quinidine-induced QTc interval prolongation in women.
Benton RE; Sale M; Flockhart DA; Woosley RL
Clin Pharmacol Ther; 2000 Apr; 67(4):413-8. PubMed ID: 10801251
[TBL] [Abstract][Full Text] [Related]
3. Kinetics and dynamics of quinidine-N-oxide in healthy subjects.
Ha HR; Vozeh S; Uematsu T; Guentert TW; Follath F
Clin Pharmacol Ther; 1987 Sep; 42(3):341-5. PubMed ID: 3621790
[TBL] [Abstract][Full Text] [Related]
4. Kinetics and electrocardiographic changes after oral 3-OH-quinidine in healthy subjects.
Vozeh S; Uematsu T; Guentert TW; Ha HR; Follath F
Clin Pharmacol Ther; 1985 May; 37(5):575-81. PubMed ID: 3987181
[TBL] [Abstract][Full Text] [Related]
5. The pharmacokinetics and pharmacodynamics of quinidine and 3-hydroxyquinidine.
Wooding-Scott RA; Smalley J; Visco J; Slaughter RL
Br J Clin Pharmacol; 1988 Oct; 26(4):415-21. PubMed ID: 3190991
[TBL] [Abstract][Full Text] [Related]
6. Antiarrhythmic activity of two quinidine metabolites in experimental reperfusion arrhythmia: relative potency and pharmacodynamic interaction with the parent drug.
Vozeh S; Oti-Amoako K; Uematsu T; Follath F
J Pharmacol Exp Ther; 1987 Oct; 243(1):297-301. PubMed ID: 3668860
[TBL] [Abstract][Full Text] [Related]
7. Specific determination of quinidine and (3S)-3-hydroxyquinidine in human serum by high-pressure liquid chromatography.
Drayer DE; Restivo K; Reidenberg MM
J Lab Clin Med; 1977 Nov; 90(5):816-22. PubMed ID: 908870
[TBL] [Abstract][Full Text] [Related]
8. Total and unbound concentrations of quinidine and 3-hydroxyquinidine at steady state.
Wooding-Scott RA; Visco J; Slaughter RL
Am Heart J; 1987 Feb; 113(2 Pt 1):302-6. PubMed ID: 3812182
[TBL] [Abstract][Full Text] [Related]
9. Effect of coadministration of verapamil and quinidine on serum digoxin concentration.
Doering W
Eur J Clin Pharmacol; 1983; 25(4):517-21. PubMed ID: 6653647
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of the cardiac electrophysiologic effects of quinidine, 3-hydroxyquinidine and 3-hydroxyhydroquinidine in the anesthesized dog. Study of plasma dose response relations].
Juliard JM; Heckle J; Jaillon P; Poirier JM; Aubry JP; Cheymol G; Jarreau FX
Arch Mal Coeur Vaiss; 1983 Jun; 76(6):670-8. PubMed ID: 6414408
[No Abstract] [Full Text] [Related]
11. The effect of quinidine and its metabolites on the electrocardiogram and systolic time intervals: concentration--effect relationships.
Holford NH; Coates PE; Guentert TW; Riegelman S; Sheiner LB
Br J Clin Pharmacol; 1981 Feb; 11(2):187-95. PubMed ID: 7213522
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the pharmacokinetic and pharmacodynamic interaction between quinidine and nifedipine.
Bowles SK; Reeves RA; Cardozo L; Edwards DJ
J Clin Pharmacol; 1993 Aug; 33(8):727-31. PubMed ID: 8408733
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the pharmacokinetic and pharmacodynamic properties of quinine and quinidine in healthy Thai males.
Karbwang J; Davis TM; Looareesuwan S; Molunto P; Bunnag D; White NJ
Br J Clin Pharmacol; 1993 Mar; 35(3):265-71. PubMed ID: 8471402
[TBL] [Abstract][Full Text] [Related]
14. Fetal supraventricular tachycardia treated with high-dose quinidine: toxicity associated with marked elevation of the metabolite, 3(S)-3-hydroxyquinidine.
Killeen AA; Bowers LD
Obstet Gynecol; 1987 Sep; 70(3 Pt 2):445-9. PubMed ID: 3627599
[TBL] [Abstract][Full Text] [Related]
15. Disposition of 3-hydroxyquinidine in patients receiving initial intravenous quinidine gluconate for electrophysiology testing of ventricular tachycardia.
Ackerman BH; Olsen KM; Kennedy EE; Taylor EH; Chen BH; Jordan D; Ackerman DJ
DICP; 1989 May; 23(5):375-8. PubMed ID: 2728524
[TBL] [Abstract][Full Text] [Related]
16. Effects of sex on the pharmacokinetic and pharmacodynamic properties of quinidine.
El-Eraky H; Thomas SH
Br J Clin Pharmacol; 2003 Aug; 56(2):198-204. PubMed ID: 12895193
[TBL] [Abstract][Full Text] [Related]
17. Method for stable measurement of the electrocardiogram in isolated guinea pig heart. Evaluation of the RR-QT relationship and the effect of quinidine.
Uematsu T; Vozeh S; Ha HR; Follath F; Nakashima M
J Pharmacol Methods; 1987 Sep; 18(2):179-85. PubMed ID: 3626572
[TBL] [Abstract][Full Text] [Related]
18. The effect of quinidine sulfate on QRS duration and QT and systolic time intervals in man.
Fieldman A; Beebe RD; Sing Sum Chow M
J Clin Pharmacol; 1977; 17(2-3):134-9. PubMed ID: 833343
[TBL] [Abstract][Full Text] [Related]
19. A high-pressure liquid chromatography method for serum quinidine and (3S)-3-hydroxyquinidine.
Weidner N; Ladenson JH; Larson L; Kessler G; McDonald JM
Clin Chim Acta; 1979 Jan; 91(1):7-13. PubMed ID: 761394
[TBL] [Abstract][Full Text] [Related]
20. Itraconazole increases plasma concentrations of quinidine.
Kaukonen KM; Olkkola KT; Neuvonen PJ
Clin Pharmacol Ther; 1997 Nov; 62(5):510-7. PubMed ID: 9390107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
